Gastric Cancer Clinical Trials

ReadTheTrial indexes 2 studies for Gastric Cancer. The most common development stage is Phase 3 (2 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

2 clinical trials found for Gastric Cancer.

Pipeline by Phase

PhaseTrialsDistribution
Phase 3 2
100%

Trial Status Breakdown

Trials for Gastric Cancer

A Multicenter, Randomised, Comparative, Open-label Phase III Aiming to Compare the Survival of Patients With Locally Advanced or Metastatic MSI/dMMR Esogastric Adenocarcinomas Treated by a Combination of Immune Checkpoint Inhibitors (Botensilimab + Balstilimab) Versus the Standard of Care (FOLFOX/XELOX + Nivolumab)

NCT06346197 · RECRUITING · Phase 3

Comparison of the Long-limb vs. Conventional Roux-en-Y Reconstruction After Distal Gastrectomy in Gastric Cancer Patients With Type II Diabetes(Multicenter Prospective Randomized Controlled Study)

NCT07437573 · COMPLETED · Phase 3

Frequently Asked Questions

What clinical trials are available for Gastric Cancer?

There are 2 clinical trials listed for Gastric Cancer. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Gastric Cancer trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Gastric Cancer trials in?

Current Gastric Cancer trials are distributed across: Phase 3 (2).

Find More Trials